Top compounds associated with response to PRELID3B


Feature Type Standardized
Nominal ANOVA
mRNA GSK269962A GDSC1000 pan-cancer AAC -0.097 0.004
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.11 0.005
mRNA masitinib GDSC1000 pan-cancer AAC -0.096 0.005
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.005
mRNA VNLG/124 GDSC1000 pan-cancer AAC -0.095 0.006
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.095 0.006
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.006
mRNA Bleomycin CTRPv2 pan-cancer AAC -0.11 0.006
mRNA S-Trityl-L-cysteine GDSC1000 pan-cancer AAC -0.14 0.006
mRNA BX-795 GDSC1000 pan-cancer AAC -0.097 0.007
Download CSV